<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">
    
    <head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
        <!-- AppResources meta begin -->
        <meta name="paf-app-resources" content="" />
                 <script type="text/javascript">var ncbi_startTime = new Date();</script>
            
        <!-- AppResources meta end -->
        
        <!-- TemplateResources meta begin -->
        <meta name="paf_template" content="" />

        <!-- TemplateResources meta end -->
        
        <!-- Logger begin -->
        <meta name="ncbi_db" content="books" /><meta name="ncbi_pdid" content="book-part" /><meta name="ncbi_acc" content="NBK532447" /><meta name="ncbi_domain" content="gene" /><meta name="ncbi_report" content="record" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/NBK532447/" /><meta name="ncbi_pagename" content="Abetalipoproteinemia - GeneReviews® - NCBI Bookshelf" /><meta name="ncbi_bookparttype" content="chapter" /><meta name="ncbi_app" content="bookshelf" />
        <!-- Logger end -->
        
        <title>Abetalipoproteinemia - GeneReviews® - NCBI Bookshelf</title>
        
        <!-- AppResources external_resources begin -->
        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>

        <!-- AppResources external_resources end -->
        
        <!-- Page meta begin -->
        <meta name="robots" content="INDEX,FOLLOW,NOARCHIVE" /><meta name="citation_inbook_title" content="GeneReviews® [Internet]" /><meta name="citation_title" content="Abetalipoproteinemia" /><meta name="citation_publisher" content="University of Washington, Seattle" /><meta name="citation_date" content="2018/10/25" /><meta name="citation_author" content="John R Burnett" /><meta name="citation_author" content="Amanda J Hooper" /><meta name="citation_author" content="Robert A Hegele" /><meta name="citation_pmid" content="30358967" /><meta name="citation_fulltext_html_url" content="https://www.ncbi.nlm.nih.gov/books/NBK532447/" /><meta name="citation_keywords" content="Bassen-Kornzweig Syndrome" /><meta name="citation_keywords" content="Bassen-Kornzweig Syndrome" /><meta name="citation_keywords" content="Microsomal triglyceride transfer protein large subunit" /><meta name="citation_keywords" content="MTTP" /><meta name="citation_keywords" content="Abetalipoproteinemia" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="DC.Title" content="Abetalipoproteinemia" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="University of Washington, Seattle" /><meta name="DC.Contributor" content="John R Burnett" /><meta name="DC.Contributor" content="Amanda J Hooper" /><meta name="DC.Contributor" content="Robert A Hegele" /><meta name="DC.Date" content="2018/10/25" /><meta name="DC.Identifier" content="https://www.ncbi.nlm.nih.gov/books/NBK532447/" /><meta name="description" content="Abetalipoproteinemia typically presents in infancy with failure to thrive, diarrhea, vomiting, and malabsorption of fat. Hematologic manifestations may include acanthocytosis (irregularly spiculated erythrocytes), anemia, reticulocytosis, and hemolysis with resultant hyperbilirubinemia. Malabsorption of fat-soluble vitamins (A, D, E, and K) can result in an increased international normalized ratio (INR). Untreated individuals may develop atypical pigmentation of the retina that may present with progressive loss of night vision and/or color vision in adulthood. Neuromuscular findings in untreated individuals including progressive loss of deep tendon reflexes, vibratory sense, and proprioception; muscle weakness; dysarthria; and ataxia typically manifest in the first or second decades of life." /><meta name="og:title" content="Abetalipoproteinemia" /><meta name="og:type" content="book" /><meta name="og:description" content="Abetalipoproteinemia typically presents in infancy with failure to thrive, diarrhea, vomiting, and malabsorption of fat. Hematologic manifestations may include acanthocytosis (irregularly spiculated erythrocytes), anemia, reticulocytosis, and hemolysis with resultant hyperbilirubinemia. Malabsorption of fat-soluble vitamins (A, D, E, and K) can result in an increased international normalized ratio (INR). Untreated individuals may develop atypical pigmentation of the retina that may present with progressive loss of night vision and/or color vision in adulthood. Neuromuscular findings in untreated individuals including progressive loss of deep tendon reflexes, vibratory sense, and proprioception; muscle weakness; dysarthria; and ataxia typically manifest in the first or second decades of life." /><meta name="og:url" content="https://www.ncbi.nlm.nih.gov/books/NBK532447/" /><meta name="og:site_name" content="NCBI Bookshelf" /><meta name="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbibooks" /><meta name="bk-non-canon-loc" content="/books/n/gene/ab-lipo-p/" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/books/NBK532447/" /><link rel="stylesheet" href="/corehtml/pmc/css/figpopup.css" type="text/css" media="screen" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books_print.min.css" type="text/css" media="print" /><style type="text/css">p a.figpopup{display:inline !important} .bk_tt {font-family: monospace}  .first-line-outdent .bk_ref {display: inline}  .body-content h2, .body-content .h2  {border-bottom: 1px solid #97B0C8} .body-content h2.inline {border-bottom: none} a.page-toc-label , .jig-ncbismoothscroll a {text-decoration:none;border:0 !important} .temp-labeled-list  .graphic {display:inline-block !important} .temp-labeled-list  img{width:100%}</style><script type="text/javascript" src="/corehtml/pmc/js/jquery.hoverIntent.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/common.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/large-obj-scrollbars.min.js"> </script><script type="text/javascript">window.name="mainwindow";</script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/book-toc.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/books.min.js"> </script><meta name="book-collection" content="NONE" />

        <!-- Page meta end -->
    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="CE8B7C18DFC854010000000005510277.m_12" />
<meta name='referrer' content='origin-when-cross-origin'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4098876/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/4008682/3881636/3579733/4062871/12930/3964959/3854974/36029/4128070/9685/3549676/3609192/3609193/3609213/3395586.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3411343/3882866.css" media="print" /></head>
    <body class="book-part">
        <div class="grid">
            <div class="col twelve_col nomargin shadow">
                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
                <div class="sysmessages">
                    <noscript>
	<p class="nojs">
	<strong>Warning:</strong>
	The NCBI web site requires JavaScript to function. 
	<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>
	</p>
	</noscript>
                </div>
                <!--/.sysmessage-->
                <div class="wrap">
                    <div class="page">
                        <div class="top">
                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list" id="navcontent"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt"><a class="ui-ncbimenu-link-first" href="/" role="banner" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo" /></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main
                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to
                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi"><span id="myncbiusername" style="display:none"><a href="/account/settings/" id="mnu" title="Edit account settings"></a></span><a accesskey="2" href="/myncbi/" id="myncbi" style="display:none">My NCBI</a><a href="/account/" id="sign_in">Sign in to NCBI</a><a href="/account/signout/" id="sign_out" style="display:none">Sign Out</a></div></div>
                            <div class="header">
    <div class="res_logo"><h1 class="res_name"><a href="/books/" title="Bookshelf home">Bookshelf</a></h1><h2 class="res_tagline"></h2></div>
    <div class="search"><form method="get" action="/books/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="books" selected="selected" class="last" data-ac_dict="bookshelf-search">Books</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books" data-ac_dict="bookshelf-search">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><input type="text" name="term" id="term" title="Search Books. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:'bookshelf-search',disableUrl:'NcbiSearchBarAutoComplCtrl'" autocomplete="off" data-sbconfig="ds:'no',pjs:'no',afs:'no'" /></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
                        <a href="/books/browse/">Browse Titles</a>
                    </li><li>
                        <a href="/books/advanced/">Advanced</a>
                    </li><li class="help">
                        <a href="/books/NBK3833/">Help</a>
                    </li></ul></div>
</div>

                            
                            
                        <!--<component id="Page" label="headcontent"/>-->
                            
                        </div>
                        <div class="content">
                            <!-- site messages -->
                            <!-- Custom content 1 -->
<div class="col1">
    
</div>

<div class="container">
    <div id="maincontent" class="content eight_col col">
        <!-- Custom content in the left column above book nav -->
        <div class="col2">
            
        </div>
        
        <!-- Book content -->
        

        <!-- Custom content between navigation and content -->
        <div class="col3">
            
        </div>
        
        <div class="document">
            <div class="pre-content"><div><div class="bk_prnt"><p class="small">NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.</p><p>Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. </p></div><div class="iconblock clearfix whole_rhythm no_top_margin bk_noprnt"><a class="img_link icnblk_img" title="All GeneReviews" href="/books/n/gene/"><img class="source-thumb" src="/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" alt="Cover of GeneReviews®" height="100px" width="80px" /></a><div class="icnblk_cntnt eight_col"><h2>GeneReviews<sup>®</sup> [Internet].</h2><a data-jig="ncbitoggler" href="#__NBK532447_dtls__">Show details</a><div style="display:none" class="ui-widget" id="__NBK532447_dtls__"><div>Adam MP, Ardinger HH, Pagon RA, et al., editors.</div><div>Seattle (WA): <a href="http://www.washington.edu" ref="pagearea=page-banner&amp;targetsite=external&amp;targetcat=link&amp;targettype=publisher">University of Washington, Seattle</a>; 1993-2019.</div></div><div class="half_rhythm"><ul class="inline_list"><li style="margin-right:1em"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a></li></ul></div><div class="bk_noprnt"><form method="get" action="/books/n/gene/" id="bk_srch"><div class="bk_search"><label for="bk_term" class="offscreen_noflow">Search term</label><input type="text" title="Search GeneReviews" id="bk_term" name="term" value="" data-jig="ncbiclearbutton" /> <input type="submit" class="jig-ncbibutton" value="Search GeneReviews" submit="false" style="padding: 0.1em 0.4em;" /></div></form><div><ul class="inline_list"><li><a href="/books/n/gene/advanced/">GeneReviews Advanced Search</a></li><li style="margin-left:.5em"><a href="/books/n/gene/helpadvsearch/">Help</a></li></ul></div></div></div><div class="icnblk_cntnt two_col"><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/pfic/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/acp/" title="Next page in this title">Next &gt;</a></div></div></div></div></div>
            <div class="main-content lit-style" itemscope="itemscope" itemtype="http://schema.org/CreativeWork"><div class="meta-content fm-sec"><h1 id="_NBK532447_"><span class="title" itemprop="name">Abetalipoproteinemia</span></h1><div itemprop="alternativeHeadline" class="subtitle whole_rhythm">Synonyms: Bassen-Kornzweig Syndrome</div><p class="contrib-group"><span itemprop="author">John R Burnett</span>, MB ChB, MD, PhD, FRCPA, <span itemprop="author">Amanda J Hooper</span>, PhD, and <span itemprop="author">Robert A Hegele</span>, MD, FRCPC, FACP.</p><a data-jig="ncbitoggler" href="#__NBK532447_ai__" style="border:0;text-decoration:none">Author Information</a><div style="display:none" class="ui-widget" id="__NBK532447_ai__"><div class="contrib half_rhythm"><span itemprop="author">John R Burnett</span>, MB ChB, MD, PhD, FRCPA<div class="affiliation small">Department of Clinical Biochemistry<br />Royal Perth Hospital &#x00026; Fiona Stanley Hospital Network<br />PathWest Laboratory Medicine WA;<br />School of Medicine<br />Faculty of Health &#x00026; Medical Sciences<br />University of Western Australia<br />Perth, Australia<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ua.vog.aw.htlaeh@ttenrub.nhoj" class="oemail">ua.vog.aw.htlaeh@ttenrub.nhoj</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Amanda J Hooper</span>, PhD<div class="affiliation small">Department of Clinical Biochemistry<br />Royal Perth Hospital &#x00026; Fiona Stanley Hospital Network<br />PathWest Laboratory Medicine WA;<br />School of Medicine<br />Faculty of Health &#x00026; Medical Sciences<br />University of Western Australia<br />Perth, Australia<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ua.vog.aw.htlaeh@repooh.adnama" class="oemail">ua.vog.aw.htlaeh@repooh.adnama</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Robert A Hegele</span>, MD, FRCPC, FACP<div class="affiliation small">Departments of Medicine and Biochemistry<br />Schulich School of Medicine and Robarts Research Institute<br />Western University<br />London, Ontario, Canada<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ac.strabor@elegeh" class="oemail">ac.strabor@elegeh</a></div></div></div></div><p class="small">Initial Posting: <span itemprop="datePublished">October 25, 2018</span>.</p><p><em>Estimated reading time: 14 minutes</em></p></div><div class="jig-ncbiinpagenav body-content whole_rhythm" data-jigconfig="allHeadingLevels: ['h2'],smoothScroll: false" itemprop="text"><div id="ab-lipo-p.Summary" itemprop="description"><h2 id="_ab-lipo-p_Summary_">Summary</h2><div><h4 class="inline">Clinical characteristics.</h4><p>Abetalipoproteinemia typically presents in infancy with failure to thrive, diarrhea, vomiting, and malabsorption of fat. Hematologic manifestations may include acanthocytosis (irregularly spiculated erythrocytes), anemia, reticulocytosis, and hemolysis with resultant hyperbilirubinemia. Malabsorption of fat-soluble vitamins (A, D, E, and K) can result in an increased international normalized ratio (INR). Untreated individuals may develop atypical pigmentation of the retina that may present with progressive loss of night vision and/or color vision in adulthood. Neuromuscular findings in untreated individuals including progressive loss of deep tendon reflexes, vibratory sense, and proprioception; muscle weakness; dysarthria; and ataxia typically manifest in the first or second decades of life.</p></div><div><h4 class="inline">Diagnosis/testing.</h4><p>The diagnosis of abetalipoproteinemia is established in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with absent or extremely low LDL-cholesterol, triglyceride, and apolipoprotein (apo) B levels and <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> pathogenic variants in <i>MTTP</i> identified by <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a>.</p></div><div><h4 class="inline">Management.</h4><p><i>Treatment of manifestations:</i> Adequate caloric intake to alleviate growth deficiency; low-fat diet (10%-20% of total calories from fat); oral essential fatty acid supplementation (up to 1 teaspoon per day of oils rich in polyunsaturated fatty acids, as tolerated); supplementation with vitamin A (100-400 IU/kg/day), vitamin D (800-1,200 IU/day), vitamin E (100-300 IU/kg/day), and vitamin K (5-35 mg/week). Mild anemia rarely requires treatment, although occasionally vitamin B12 or iron therapy may be considered. Dysarthria, ataxia, and hypothyroidism are treated in the standard fashion.</p><p><i>Prevention of primary manifestations:</i> Most complications can be prevented through institution of a low-fat diet with supplementation of fat-soluble vitamins (A, D, E, and K).</p><p><i>Surveillance:</i> Assessment of growth parameters at each visit. Complete blood count, INR, reticulocyte count, liver function tests (AST, ALT, GGT, total and direct bilirubin, alkaline phosphatase, and albumin), fat-soluble vitamin levels (vitamin A [retinol], 25-OH vitamin D, and plasma or red blood cell vitamin E concentrations), serum calcium, serum phosphate, serum uric acid, and TSH levels annually. Lipid profile (total cholesterol, triglyceride concentration, LDL-cholesterol, HDL-cholesterol, apo B, and apo A-I) every several years. Ultrasound of the liver every three years. Ophthalmology and neurology evaluations every six to 12 months.</p><p><i>Agents/circumstances to avoid:</i> Fatty foods, particularly those rich in long-chain fatty acids.</p><p><i>Evaluation of relatives at risk</i>: Sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> should undergo a full lipid profile and apolipoprotein (apo) B determination to allow for early diagnosis and treatment of findings. If the pathogenic <i>MTTP</i> variants in the family are known, <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> may also be used to determine the genetic status of at-risk sibs. In classic abetalipoproteinemia, <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> sibs will present shortly after birth with failure to thrive, diarrhea, vomiting, and malabsorption of fat.</p><p><i>Pregnancy management</i>: Vitamin A excess can be harmful to the developing fetus. Therefore, women who are pregnant or who are planning to become pregnant should reduce their vitamin A supplement dose by 50%. Additionally, close monitoring of serum beta carotene levels throughout pregnancy is recommended. Because vitamin A is an essential vitamin, vitamin A supplementation should not be discontinued during pregnancy.</p></div><div><h4 class="inline">Genetic counseling.</h4><p>Abetalipoproteinemia is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> manner. At conception, each sib of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual has a 25% chance of being affected, a 50% chance of being an asymptomatic <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a>, and a 25% chance of being unaffected and not a carrier. Carrier testing for at-risk relatives, <a class="def" href="/books/n/gene/glossary/def-item/prenatal-diagnosis/">prenatal diagnosis</a> for pregnancies at increased risk, and <a class="def" href="/books/n/gene/glossary/def-item/preimplantation-genetic-diagnosis/">preimplantation genetic diagnosis</a> are possible if the pathogenic <i>MTTP</i> variants in the family are known.</p></div></div><div id="ab-lipo-p.Diagnosis"><h2 id="_ab-lipo-p_Diagnosis_">Diagnosis</h2><p>No formal clinical diagnostic criteria for abetalipoproteinemia have been published.</p><div id="ab-lipo-p.Suggestive_Findings"><h3>Suggestive Findings</h3><p>Classic abetalipoproteinemia presents from birth with failure to thrive, severe diarrhea and vomiting, and malabsorption of fat. Abetalipoproteinemia <b>should be suspected</b> in children with the following clinical and supportive laboratory findings [<a class="bk_pop" href="#ab-lipo-p.REF.lee.2014.333">Lee &#x00026; Hegele 2014</a>].</p><p><b>Clinical features</b></p><ul><li class="half_rhythm"><div>Failure to thrive, with diarrhea and vomiting</div></li><li class="half_rhythm"><div>Fat malabsorption with steatorrhea</div></li><li class="half_rhythm"><div>Hepatomegaly</div></li><li class="half_rhythm"><div>Loss of night and/or color vision</div></li><li class="half_rhythm"><div>Acquired atypical pigmentation of the retina</div></li><li class="half_rhythm"><div>Spinocerebellar ataxia and myopathy</div></li></ul><p><b>Supportive laboratory findings</b></p><ul><li class="half_rhythm"><div>Marked hypocholesterolemia (total cholesterol ~1 mmol/L [~40 mg/dL])</div></li><li class="half_rhythm"><div>Plasma LDL-cholesterol (measured or calculated) absent or extremely low</div></li><li class="half_rhythm"><div>Plasma apo B absent or very low</div></li><li class="half_rhythm"><div>Plasma triglyceride very low</div></li><li class="half_rhythm"><div>Plasma HDL-cholesterol at a low to average level</div></li><li class="half_rhythm"><div>Acanthocytosis</div></li><li class="half_rhythm"><div>Abnormal liver transaminases (AST and ALT 1-1.5 times the upper reference limit)</div></li><li class="half_rhythm"><div>Prolonged international normalized ratio (INR)</div></li><li class="half_rhythm"><div>Low serum concentrations of fat-soluble vitamins (A, D, E, and K)</div></li></ul></div><div id="ab-lipo-p.Establishing_the_Diagnosis"><h3>Establishing the Diagnosis</h3><p>The diagnosis of abetalipoproteinemia <b>is established</b> in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with absent or extremely low LDL-cholesterol, triglyceride, and apo B levels and <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> pathogenic variants in <i>MTTP</i> identified by <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> (see <a class="figpopup" href="/books/NBK532447/table/ab-lipo-p.T.molecular_genetic_testing_us/?report=objectonly" target="object" rid-figpopup="figablipopTmoleculargenetictestingus" rid-ob="figobablipopTmoleculargenetictestingus">Table 1</a>).</p><p>When the phenotypic and laboratory findings suggest the diagnosis of abetalipoproteinemia, <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> approaches can include <b>single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing</b> and use of a <b><a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b>.</p><p><b>Single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing.</b> Sequence analysis of <i>MTTP</i> detects small intragenic deletions/insertions and <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>, <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, and <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variants; typically, <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-gene deletions/duplications are not detected.</p><dl class="temp-labeled-list"><dt>1.</dt><dd><p class="no_top_margin">Perform <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> first.</p></dd><dt>2.</dt><dd><p class="no_top_margin">If only one or no <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> is found, perform <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> to detect intragenic deletions or duplications.</p></dd></dl><p><b>A <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b> that includes <i>MTTP</i> and other genes of interest (see <a href="#ab-lipo-p.Differential_Diagnosis">Differential Diagnosis</a>) is most likely to identify the genetic cause of the condition at the most reasonable cost while limiting identification of variants of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a> and pathogenic variants in genes that do not explain the underlying <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>. Note: (1) The genes included in the panel and the diagnostic <a class="def" href="/books/n/gene/glossary/def-item/sensitivity/">sensitivity</a> of the testing used for each <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> vary by laboratory and are likely to change over time. (2) Some multigene panels may include genes not associated with the condition discussed in this <i>GeneReview</i>. (3) In some laboratories, panel options may include a custom laboratory-designed panel and/or custom phenotype-focused <a class="def" href="/books/n/gene/glossary/def-item/exome/">exome</a> analysis that includes genes specified by the clinician. (4) Methods used in a panel may include <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a>, <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>, and/or other non-sequencing-based tests.</p><p>For an introduction to multigene panels click <a href="/books/n/gene/app5/#app5.Multigene_Panels">here</a>. More detailed information for clinicians ordering genetic tests can be found <a href="/books/n/gene/app5/#app5.Multigene_Panels_FAQs">here</a>.</p><div id="ab-lipo-p.T.molecular_genetic_testing_us" class="table"><h3><span class="label">Table 1. </span></h3><div class="caption"><p>Molecular Genetic Testing Used in Abetalipoproteinemia</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK532447/table/ab-lipo-p.T.molecular_genetic_testing_us/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__ab-lipo-p.T.molecular_genetic_testing_us_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_ab-lipo-p.T.molecular_genetic_testing_us_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Gene&#x000a0;<sup>1</sup></th><th id="hd_h_ab-lipo-p.T.molecular_genetic_testing_us_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Test Method</th><th id="hd_h_ab-lipo-p.T.molecular_genetic_testing_us_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Proportion of Probands with Pathogenic Variants&#x000a0;<sup>2</sup> Detectable by This Method</th></tr></thead><tbody><tr><td headers="hd_h_ab-lipo-p.T.molecular_genetic_testing_us_1_1_1_1" rowspan="2" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><i>MTTP</i></td><td headers="hd_h_ab-lipo-p.T.molecular_genetic_testing_us_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Sequence analysis&#x000a0;<sup>3</sup></td><td headers="hd_h_ab-lipo-p.T.molecular_genetic_testing_us_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">59/60</td></tr><tr><td headers="hd_h_ab-lipo-p.T.molecular_genetic_testing_us_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>&#x000a0;<sup>4</sup></td><td headers="hd_h_ab-lipo-p.T.molecular_genetic_testing_us_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">1/60&#x000a0;<sup>5</sup></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt>1. </dt><dd><div id="ab-lipo-p.TF.1.1"><p class="no_margin">See <a href="/books/NBK532447/#ab-lipo-p.molgen.TA">Table A. Genes and Databases</a> for <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> and protein.</p></div></dd><dt>2. </dt><dd><div id="ab-lipo-p.TF.1.2"><p class="no_margin">See <a href="#ab-lipo-p.Molecular_Genetics">Molecular Genetics</a> for information on allelic variants detected in this <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>.</p></div></dd><dt>3. </dt><dd><div id="ab-lipo-p.TF.1.3"><p class="no_margin">Sequence analysis detects variants that are benign, likely benign, of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a>, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>, <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, and <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variants; typically, <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions/duplications are not detected. For issues to consider in interpretation of <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> results, click <a href="/books/n/gene/app2/">here</a>.</p></div></dd><dt>4. </dt><dd><div id="ab-lipo-p.TF.1.4"><p class="no_margin">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> detects intragenic deletions or duplications. Methods used may include: <a class="def" href="/books/n/gene/glossary/def-item/quantitative-pcr/">quantitative PCR</a>, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and a <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted microarray designed to detect single-<a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> deletions or duplications.</p></div></dd><dt>5. </dt><dd><div id="ab-lipo-p.TF.1.5"><p class="no_margin">R Hegele, personal observation</p></div></dd></dl></div></div></div></div></div><div id="ab-lipo-p.Clinical_Characteristics"><h2 id="_ab-lipo-p_Clinical_Characteristics_">Clinical Characteristics</h2><div id="ab-lipo-p.Clinical_Description"><h3>Clinical Description</h3><p>Abetalipoproteinemia typically presents in infancy with failure to thrive, diarrhea, vomiting, and malabsorption of fat. The absence of apo B-containing lipoproteins and resulting deficiency of fat-soluble vitamins lead to multisystem manifestations as the <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual ages.</p><p><b>Gastrointestinal.</b> Steatorrhea is the primary gastrointestinal manifestation. The severity relates to the fat content of the diet.</p><ul><li class="half_rhythm"><div class="half_rhythm">As <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals age they learn to avoid dietary fat, which improves steatorrhea [<a class="bk_pop" href="#ab-lipo-p.REF.kane.2001">Kane &#x00026; Havel 2001</a>].</div></li><li class="half_rhythm"><div class="half_rhythm">Hepatic involvement as identified on laboratory studies is frequently stable over many years and may not evolve to be clinically significant [<a class="bk_pop" href="#ab-lipo-p.REF.lee.2014.333">Lee &#x00026; Hegele 2014</a>].</div></li><li class="half_rhythm"><div class="half_rhythm">Hepatomegaly and hepatic steatosis can be observed, which rarely may progress to steatohepatitis, fibrosis, and cirrhosis [<a class="bk_pop" href="#ab-lipo-p.REF.di_filippo.2014.891">Di Filippo et al 2014</a>].</div></li><li class="half_rhythm"><div class="half_rhythm">On a typical diet (e.g., no dietary fat restriction), the intestinal mucosa may have a "gelee blanche" or "white hoar frosting" appearance on endoscopy.</div><div class="half_rhythm">Biopsy of the intestinal epithelium may demonstrate lipid-laden intestinal epithelial cells.</div></li></ul><p><b>Hematologic</b> manifestations of abetalipoproteinemia include the following:</p><ul><li class="half_rhythm"><div>Acanthocytosis, defined as irregularly spiculated erythrocytes</div></li><li class="half_rhythm"><div>Low erythrocyte sedimentation rate</div></li><li class="half_rhythm"><div>Anemia</div></li><li class="half_rhythm"><div>Reticulocytosis</div></li><li class="half_rhythm"><div>Hyperbilirubinemia</div></li><li class="half_rhythm"><div>Hemolysis</div></li><li class="half_rhythm"><div>Prolonged INR due to vitamin K deficiency [<a class="bk_pop" href="#ab-lipo-p.REF.kane.2001">Kane &#x00026; Havel 2001</a>]</div></li></ul><p><b>Ophthalmologic</b> manifestations of abetalipoproteinemia are variable, with the most prominent being an atypical pigmentation of the retina [<a class="bk_pop" href="#ab-lipo-p.REF.cogan.1984.991">Cogan et al 1984</a>].</p><ul><li class="half_rhythm"><div>Many <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals are asymptomatic until adulthood, when they experience loss of night vision and/or color vision.</div></li><li class="half_rhythm"><div>As the disease progresses, <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals may experience progressively expanding scotomas.</div></li><li class="half_rhythm"><div>Without treatment, progression to complete visual loss may occur.</div></li><li class="half_rhythm"><div>Other rare, typically acquired, ophthalmologic findings include the following:</div><ul><li class="half_rhythm"><div>Ptosis</div></li><li class="half_rhythm"><div>Ophthalmoplegia</div></li><li class="half_rhythm"><div>Corneal ulcers</div></li></ul></li></ul><p>It is hypothesized that the possible cause of ptosis and ophthalmoplegia is vitamin E deficiency leading to cranial nerve demyelination. Corneal ulcers may be caused or exacerbated by vitamin A deficiency [<a class="bk_pop" href="#ab-lipo-p.REF.lee.2014.333">Lee &#x00026; Hegele 2014</a>].</p><p><b>Neuromuscular.</b> If untreated, neuromuscular manifestations of abetalipoproteinemia secondary to the deficiency of vitamin E typically begin in the first or second decade of life. Symptoms include the following:</p><ul><li class="half_rhythm"><div>Progressive loss of deep tendon reflexes, vibratory sense, and proprioception</div></li><li class="half_rhythm"><div>Muscle weakness</div></li><li class="half_rhythm"><div>Dysarthria</div></li><li class="half_rhythm"><div>Eventually, a Friedrich's-like ataxia, with a broad base and high stepping gait, can develop in early adulthood in untreated individuals [<a class="bk_pop" href="#ab-lipo-p.REF.tanyel.1997.197">Tanyel &#x00026; Mancano 1997</a>].</div></li></ul><p><b>Cardiac.</b> Although rare, cardiomegaly can occur after decades, with rare death related to cardiomyopathy reported.</p><p><b>Endocrinologic.</b> Although rare, both subclinical and overt hypothyroidism have been reported in individuals with abetalipoproteinemia.</p><p><b>Prognosis.</b> In the past, without high-dose fat-soluble vitamin supplementation, <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals would typically not survive past the third decade of life, dying with severe neuromyopathy and respiratory failure. With lifelong high-dose oral fat-soluble vitamin treatment, longevity into the seventh and eighth decade of life, with relatively minimal symptoms, has been reported.</p></div><div id="ab-lipo-p.GenotypePhenotype_Correlations"><h3>Genotype-Phenotype Correlations</h3><p>Due to the small number of individuals with abetalipoproteinemia reported in the literature, reliable data on <a class="def" href="/books/n/gene/glossary/def-item/genotype-phenotype-correlations/">genotype-phenotype correlations</a> are lacking.</p></div><div id="ab-lipo-p.Penetrance"><h3>Penetrance</h3><p>While 100% of individuals either <a class="def" href="/books/n/gene/glossary/def-item/homozygous/">homozygous</a> or <a class="def" href="/books/n/gene/glossary/def-item/compound-heterozygous/">compound heterozygous</a> for pathogenic <i>MTTP</i> variants will have a biochemical diagnosis of abetalipoproteinemia, the <a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a> of clinical symptoms is variable, increases with age, and may be incomplete [<a class="bk_pop" href="#ab-lipo-p.REF.paquette.2016.1030">Paquette et al 2016</a>]. The disorder affects males and females equally.</p></div><div id="ab-lipo-p.Nomenclature"><h3>Nomenclature</h3><p>Abetalipoproteinemia was initially named Bassen-Kornzweig syndrome.</p></div><div id="ab-lipo-p.Prevalence"><h3>Prevalence</h3><p>Abetalipoproteinemia is rare; fewer than 100 individuals have been described in the literature.</p></div></div><div id="ab-lipo-p.Genetically_Related_Allelic_Di"><h2 id="_ab-lipo-p_Genetically_Related_Allelic_Di_">Genetically Related (Allelic) Disorders</h2><p>No phenotypes other than those discussed in this <i>GeneReview</i> are known to be associated with pathogenic variants in <i>MTTP</i>.</p></div><div id="ab-lipo-p.Differential_Diagnosis"><h2 id="_ab-lipo-p_Differential_Diagnosis_">Differential Diagnosis</h2><div id="ab-lipo-p.T.disorders_to_consider_in_the" class="table"><h3><span class="label">Table 2. </span></h3><div class="caption"><p>Disorders to Consider in the Differential Diagnosis of Abetalipoproteinemia</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK532447/table/ab-lipo-p.T.disorders_to_consider_in_the/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__ab-lipo-p.T.disorders_to_consider_in_the_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_ab-lipo-p.T.disorders_to_consider_in_the_1_1_1_1" rowspan="2" scope="col" colspan="1" headers="hd_h_ab-lipo-p.T.disorders_to_consider_in_the_1_1_1_1" style="text-align:left;vertical-align:middle;">Disorder</th><th id="hd_h_ab-lipo-p.T.disorders_to_consider_in_the_1_1_1_2" rowspan="2" scope="col" colspan="1" headers="hd_h_ab-lipo-p.T.disorders_to_consider_in_the_1_1_1_2" style="text-align:left;vertical-align:middle;">Gene</th><th id="hd_h_ab-lipo-p.T.disorders_to_consider_in_the_1_1_1_3" rowspan="2" scope="col" colspan="1" headers="hd_h_ab-lipo-p.T.disorders_to_consider_in_the_1_1_1_3" style="text-align:left;vertical-align:middle;">MOI</th><th id="hd_h_ab-lipo-p.T.disorders_to_consider_in_the_1_1_1_4" colspan="2" scope="colgroup" rowspan="1" style="text-align:left;vertical-align:middle;">Clinical Features of This Disorder</th></tr><tr><th headers="hd_h_ab-lipo-p.T.disorders_to_consider_in_the_1_1_1_4" id="hd_h_ab-lipo-p.T.disorders_to_consider_in_the_1_1_2_1" colspan="1" scope="colgroup" rowspan="1" style="text-align:left;vertical-align:middle;">Overlapping w/abetalipoproteinemia</th><th headers="hd_h_ab-lipo-p.T.disorders_to_consider_in_the_1_1_1_4" id="hd_h_ab-lipo-p.T.disorders_to_consider_in_the_1_1_2_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Distinguishing from abetalipoproteinemia</th></tr></thead><tbody><tr><td headers="hd_h_ab-lipo-p.T.disorders_to_consider_in_the_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Homozygous<br />hypobetalipoproteinemia<br />(OMIM <a href="https://omim.org/entry/615558" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">615558</a>)</td><td headers="hd_h_ab-lipo-p.T.disorders_to_consider_in_the_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>APOB</i></td><td headers="hd_h_ab-lipo-p.T.disorders_to_consider_in_the_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_ab-lipo-p.T.disorders_to_consider_in_the_1_1_1_4 hd_h_ab-lipo-p.T.disorders_to_consider_in_the_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Clinical features are indistinguishable.</td><td headers="hd_h_ab-lipo-p.T.disorders_to_consider_in_the_1_1_1_4 hd_h_ab-lipo-p.T.disorders_to_consider_in_the_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">The only distinguishing feature is the pattern of inheritance: in abetalipoproteinemia the lipid levels in <a class="def" href="/books/n/gene/glossary/def-item/obligate-heterozygote/">obligate heterozygote</a> parents are normal; in hypobetalipoproteinemia LDL-cholesterol levels are &#x0003c;50% of normal.</td></tr><tr><td headers="hd_h_ab-lipo-p.T.disorders_to_consider_in_the_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">McLeod syndrome<br />(OMIM <a href="https://omim.org/entry/300842" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">300842</a>)</td><td headers="hd_h_ab-lipo-p.T.disorders_to_consider_in_the_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>XK</i></td><td headers="hd_h_ab-lipo-p.T.disorders_to_consider_in_the_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">XL</td><td headers="hd_h_ab-lipo-p.T.disorders_to_consider_in_the_1_1_1_4 hd_h_ab-lipo-p.T.disorders_to_consider_in_the_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Acanthocytosis</div></li><li class="half_rhythm"><div>Peripheral neuropathy</div></li></ul>
</td><td headers="hd_h_ab-lipo-p.T.disorders_to_consider_in_the_1_1_1_4 hd_h_ab-lipo-p.T.disorders_to_consider_in_the_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">McLeod syndrome is <a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a>; <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals have normal lipid profiles &#x00026; no manifestations of fat-soluble vitamin deficiency (e.g., retinal disease, bone abnormalities, coagulopathy)</td></tr><tr><td headers="hd_h_ab-lipo-p.T.disorders_to_consider_in_the_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="https://www.ncbi.nlm.nih.gov/books/NBK1281/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Friedreich ataxia</a></td><td headers="hd_h_ab-lipo-p.T.disorders_to_consider_in_the_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>FXN</i></td><td headers="hd_h_ab-lipo-p.T.disorders_to_consider_in_the_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_ab-lipo-p.T.disorders_to_consider_in_the_1_1_1_4 hd_h_ab-lipo-p.T.disorders_to_consider_in_the_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Broad based, high stepping gait</div></li><li class="half_rhythm"><div>Loss of proprioception</div></li><li class="half_rhythm"><div>Loss of deep tendon reflexes</div></li></ul>
</td><td headers="hd_h_ab-lipo-p.T.disorders_to_consider_in_the_1_1_1_4 hd_h_ab-lipo-p.T.disorders_to_consider_in_the_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Affected individuals have normal lipid profiles &#x00026; no manifestations of fat-soluble vitamin deficiency (e.g., retinal disease, bone abnormalities, coagulopathy)</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">AD = <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a>; AR = <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a>; MOI = <a class="def" href="/books/n/gene/glossary/def-item/mode-of-inheritance/">mode of inheritance</a>; XL = <a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a></p></div></dd></dl></div></div></div></div><div id="ab-lipo-p.Management"><h2 id="_ab-lipo-p_Management_">Management</h2><div id="ab-lipo-p.Evaluations_Following_Initial"><h3>Evaluations Following Initial Diagnosis</h3><p>To establish the extent of disease and needs in an individual diagnosed with abetalipoproteinemia, the evaluations summarized in <a class="figpopup" href="/books/NBK532447/table/ab-lipo-p.T.recommended_evaluations_foll/?report=objectonly" target="object" rid-figpopup="figablipopTrecommendedevaluationsfoll" rid-ob="figobablipopTrecommendedevaluationsfoll">Table 3</a> (if not performed as part of the evaluation that led to the diagnosis) are recommended:</p><div id="ab-lipo-p.T.recommended_evaluations_foll" class="table"><h3><span class="label">Table 3. </span></h3><div class="caption"><p>Recommended Evaluations Following Initial Diagnosis in Individuals with Abetalipoproteinemia</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK532447/table/ab-lipo-p.T.recommended_evaluations_foll/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__ab-lipo-p.T.recommended_evaluations_foll_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_ab-lipo-p.T.recommended_evaluations_foll_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Organ System</th><th id="hd_h_ab-lipo-p.T.recommended_evaluations_foll_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Evaluation</th><th id="hd_h_ab-lipo-p.T.recommended_evaluations_foll_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Comment</th></tr></thead><tbody><tr><td headers="hd_h_ab-lipo-p.T.recommended_evaluations_foll_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>General</b></td><td headers="hd_h_ab-lipo-p.T.recommended_evaluations_foll_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Growth parameters</td><td headers="hd_h_ab-lipo-p.T.recommended_evaluations_foll_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">To assess for poor growth</td></tr><tr><td headers="hd_h_ab-lipo-p.T.recommended_evaluations_foll_1_1_1_1" rowspan="6" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><b>Gastrointestinal</b></td><td headers="hd_h_ab-lipo-p.T.recommended_evaluations_foll_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Fecal fat</td><td headers="hd_h_ab-lipo-p.T.recommended_evaluations_foll_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_ab-lipo-p.T.recommended_evaluations_foll_1_1_1_2" colspan="1" scope="col" rowspan="1" style="text-align:left;vertical-align:middle;">Serum lipid profile:
<ul><li class="half_rhythm"><div>Total cholesterol</div></li><li class="half_rhythm"><div>LDL-cholesterol</div></li><li class="half_rhythm"><div>HDL-cholesterol</div></li><li class="half_rhythm"><div>Triglyceride</div></li><li class="half_rhythm"><div>Apo B</div></li><li class="half_rhythm"><div>Apo A-I</div></li></ul>
</td><td headers="hd_h_ab-lipo-p.T.recommended_evaluations_foll_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_ab-lipo-p.T.recommended_evaluations_foll_1_1_1_2" colspan="1" scope="col" rowspan="1" style="text-align:left;vertical-align:middle;">Serum concentrations of fat-soluble vitamins (A, D, E, K)</td><td headers="hd_h_ab-lipo-p.T.recommended_evaluations_foll_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_ab-lipo-p.T.recommended_evaluations_foll_1_1_1_2" colspan="1" scope="col" rowspan="1" style="text-align:left;vertical-align:middle;">Liver transaminases &#x00026; bilirubin levels</td><td headers="hd_h_ab-lipo-p.T.recommended_evaluations_foll_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_ab-lipo-p.T.recommended_evaluations_foll_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Referral to nutritionist</td><td headers="hd_h_ab-lipo-p.T.recommended_evaluations_foll_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">To provide dietary advice about low-fat diet</td></tr><tr><td headers="hd_h_ab-lipo-p.T.recommended_evaluations_foll_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Abdominal ultrasound</td><td headers="hd_h_ab-lipo-p.T.recommended_evaluations_foll_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">To evaluate for steatohepatitis, fibrosis, &#x00026;/or cirrhosis</td></tr><tr><td headers="hd_h_ab-lipo-p.T.recommended_evaluations_foll_1_1_1_1" rowspan="2" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><b>Hematologic</b></td><td headers="hd_h_ab-lipo-p.T.recommended_evaluations_foll_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Complete blood count</td><td headers="hd_h_ab-lipo-p.T.recommended_evaluations_foll_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">To evaluate for anemia &#x00026;/or hemolysis</td></tr><tr><td headers="hd_h_ab-lipo-p.T.recommended_evaluations_foll_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">INR</td><td headers="hd_h_ab-lipo-p.T.recommended_evaluations_foll_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">To evaluate for &#x02191; risk of bleeding</td></tr><tr><td headers="hd_h_ab-lipo-p.T.recommended_evaluations_foll_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Ophthalmologic</b></td><td headers="hd_h_ab-lipo-p.T.recommended_evaluations_foll_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Referral to ophthalmologist</td><td headers="hd_h_ab-lipo-p.T.recommended_evaluations_foll_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">For evaluation of visual acuity &#x00026; pigmentary retinopathy</td></tr><tr><td headers="hd_h_ab-lipo-p.T.recommended_evaluations_foll_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Neurologic</b></td><td headers="hd_h_ab-lipo-p.T.recommended_evaluations_foll_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Referral to neurologist</td><td headers="hd_h_ab-lipo-p.T.recommended_evaluations_foll_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">If evidence of neurologic abnormality (e.g., ataxia, loss of deep tendon reflexes)</td></tr><tr><td headers="hd_h_ab-lipo-p.T.recommended_evaluations_foll_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Endocrinologic</b></td><td headers="hd_h_ab-lipo-p.T.recommended_evaluations_foll_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Thyroid stimulating hormone (TSH)</td><td headers="hd_h_ab-lipo-p.T.recommended_evaluations_foll_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">While thyroid function is not typically abnormal, TSH should be evaluated at least 1x.</td></tr><tr><td headers="hd_h_ab-lipo-p.T.recommended_evaluations_foll_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Other</b></td><td headers="hd_h_ab-lipo-p.T.recommended_evaluations_foll_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Consultation w/clinical geneticist &#x00026;/or genetic counselor</td><td headers="hd_h_ab-lipo-p.T.recommended_evaluations_foll_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">HDL = high-density lipoprotein; INR = international normalized ratio; LDL = low-density lipoprotein</p></div></dd></dl></div></div></div></div><div id="ab-lipo-p.Treatment_of_Manifestations"><h3>Treatment of Manifestations</h3><p>The following treatment is recommended for abetalipoproteinemia to address symptoms and prevent complications [<a class="bk_pop" href="#ab-lipo-p.REF.lee.2014.333">Lee &#x00026; Hegele 2014</a>]:</p><div id="ab-lipo-p.T.treatment_of_manifestations" class="table"><h3><span class="label">Table 4. </span></h3><div class="caption"><p>Treatment of Manifestations in Individuals with Abetalipoproteinemia</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK532447/table/ab-lipo-p.T.treatment_of_manifestations/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__ab-lipo-p.T.treatment_of_manifestations_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_ab-lipo-p.T.treatment_of_manifestations_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Manifestation</th><th id="hd_h_ab-lipo-p.T.treatment_of_manifestations_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Treatment</th><th id="hd_h_ab-lipo-p.T.treatment_of_manifestations_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Considerations/Other</th></tr></thead><tbody><tr><td headers="hd_h_ab-lipo-p.T.treatment_of_manifestations_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Growth deficiency</td><td headers="hd_h_ab-lipo-p.T.treatment_of_manifestations_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Ensure adequate caloric intake.&#x000a0;<sup>1</sup></td><td headers="hd_h_ab-lipo-p.T.treatment_of_manifestations_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Referral to a nutritionist may be considered.</td></tr><tr><td headers="hd_h_ab-lipo-p.T.treatment_of_manifestations_1_1_1_1" rowspan="2" scope="row" colspan="1" style="text-align:left;vertical-align:middle;">Steatorrhea</td><td headers="hd_h_ab-lipo-p.T.treatment_of_manifestations_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Low-fat diet (10%-20% of total calories)&#x000a0;<sup>2</sup></td><td headers="hd_h_ab-lipo-p.T.treatment_of_manifestations_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Total fat intake of &#x0003e;20% is not likely to be tolerated.</td></tr><tr><td headers="hd_h_ab-lipo-p.T.treatment_of_manifestations_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Oral essential fatty acid supplementation</td><td headers="hd_h_ab-lipo-p.T.treatment_of_manifestations_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x02264;1 tsp/day of oils rich in polyunsaturated fatty acids (e.g., soybean or olive oil) as tolerated</td></tr><tr><td headers="hd_h_ab-lipo-p.T.treatment_of_manifestations_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Steatotic liver w/out fibrosis</td><td headers="hd_h_ab-lipo-p.T.treatment_of_manifestations_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Restriction of dietary fat</td><td headers="hd_h_ab-lipo-p.T.treatment_of_manifestations_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Because fatty liver develops w/out active inflammation, no need for anti-inflammatory treatment</td></tr><tr><td headers="hd_h_ab-lipo-p.T.treatment_of_manifestations_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Hepatic fibrosis &#x00026;/or cirrhosis</td><td headers="hd_h_ab-lipo-p.T.treatment_of_manifestations_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Liver transplantation may be considered.&#x000a0;<sup>3</sup></td><td headers="hd_h_ab-lipo-p.T.treatment_of_manifestations_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">A very rare complication, especially w/early diagnosis &#x00026; treatment</td></tr><tr><td headers="hd_h_ab-lipo-p.T.treatment_of_manifestations_1_1_1_1" rowspan="4" scope="row" colspan="1" style="text-align:left;vertical-align:middle;">Deficiency of fat-soluble vitamins</td><td headers="hd_h_ab-lipo-p.T.treatment_of_manifestations_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Vitamin A (100-400 IU/kg/day)&#x000a0;<sup>4,&#x000a0;5,&#x000a0;6</sup></td><td headers="hd_h_ab-lipo-p.T.treatment_of_manifestations_1_1_1_3" rowspan="4" colspan="1" style="text-align:left;vertical-align:middle;">Supplemental vitamins should be given orally; intravenous administration of fat-soluble vitamins is not necessary.</td></tr><tr><td headers="hd_h_ab-lipo-p.T.treatment_of_manifestations_1_1_1_2" colspan="1" scope="col" rowspan="1" style="text-align:left;vertical-align:middle;">Vitamin D (800-1,200 IU/day)</td></tr><tr><td headers="hd_h_ab-lipo-p.T.treatment_of_manifestations_1_1_1_2" colspan="1" scope="col" rowspan="1" style="text-align:left;vertical-align:middle;">Vitamin E (100-300 IU/kg/day)&#x000a0;<sup>7</sup></td></tr><tr><td headers="hd_h_ab-lipo-p.T.treatment_of_manifestations_1_1_1_2" colspan="1" scope="col" rowspan="1" style="text-align:left;vertical-align:middle;">Vitamin K (5-35 mg/week)</td></tr><tr><td headers="hd_h_ab-lipo-p.T.treatment_of_manifestations_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Anemia</td><td headers="hd_h_ab-lipo-p.T.treatment_of_manifestations_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Mild anemia typically requires no treatment; occasionally vitamin B<sub>12</sub> or iron is given in addition to fat-soluble vitamins.</td><td headers="hd_h_ab-lipo-p.T.treatment_of_manifestations_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_ab-lipo-p.T.treatment_of_manifestations_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Increased INR</td><td headers="hd_h_ab-lipo-p.T.treatment_of_manifestations_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Vitamin K supplementation (see above)</td><td headers="hd_h_ab-lipo-p.T.treatment_of_manifestations_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_ab-lipo-p.T.treatment_of_manifestations_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Abnormal visual acuity</td><td headers="hd_h_ab-lipo-p.T.treatment_of_manifestations_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Vitamin A supplementation (see above) can arrest the progression of visual impairment &#x00026; prevent development of eye complications.</td><td headers="hd_h_ab-lipo-p.T.treatment_of_manifestations_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_ab-lipo-p.T.treatment_of_manifestations_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Dysarthria</td><td headers="hd_h_ab-lipo-p.T.treatment_of_manifestations_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Speech &#x00026; language therapy</td><td headers="hd_h_ab-lipo-p.T.treatment_of_manifestations_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">W/early vitamin E supplementation dysarthria is rare.</td></tr><tr><td headers="hd_h_ab-lipo-p.T.treatment_of_manifestations_1_1_1_1" rowspan="5" scope="row" colspan="1" style="text-align:left;vertical-align:middle;">Ataxia</td><td headers="hd_h_ab-lipo-p.T.treatment_of_manifestations_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Intensive rehabilitation (or coordinative physiotherapy)</td><td headers="hd_h_ab-lipo-p.T.treatment_of_manifestations_1_1_1_3" rowspan="5" colspan="1" style="text-align:left;vertical-align:middle;">Treatment best provided by a multidisciplinary team comprising a neurologist, physiatrist, &#x00026; physical &#x00026; occupational therapists</td></tr><tr><td headers="hd_h_ab-lipo-p.T.treatment_of_manifestations_1_1_1_2" colspan="1" scope="col" rowspan="1" style="text-align:left;vertical-align:middle;">Canes/walkers to prevent falls</td></tr><tr><td headers="hd_h_ab-lipo-p.T.treatment_of_manifestations_1_1_1_2" colspan="1" scope="col" rowspan="1" style="text-align:left;vertical-align:middle;">Home modifications to accommodate motorized chairs, as needed</td></tr><tr><td headers="hd_h_ab-lipo-p.T.treatment_of_manifestations_1_1_1_2" colspan="1" scope="col" rowspan="1" style="text-align:left;vertical-align:middle;">Weighted eating utensils &#x00026; dressing hooks</td></tr><tr><td headers="hd_h_ab-lipo-p.T.treatment_of_manifestations_1_1_1_2" colspan="1" scope="col" rowspan="1" style="text-align:left;vertical-align:middle;">Weight control, as obesity can exacerbate difficulties w/ambulation &#x00026; mobility</td></tr><tr><td headers="hd_h_ab-lipo-p.T.treatment_of_manifestations_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Hypothyroidism</td><td headers="hd_h_ab-lipo-p.T.treatment_of_manifestations_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Standard treatment w/thyroid hormone replacement</td><td headers="hd_h_ab-lipo-p.T.treatment_of_manifestations_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">INR = international normalized ratio</p></div></dd><dt>1. </dt><dd><div id="ab-lipo-p.TF.4.1"><p class="no_margin">With proper treatment, a normal growth velocity can be achieved in <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals; however, affected individuals may not meet their full growth potential, even after treatment [<a class="bk_pop" href="#ab-lipo-p.REF.lee.2014.333">Lee &#x00026; Hegele 2014</a>].</p></div></dd><dt>2. </dt><dd><div id="ab-lipo-p.TF.4.2"><p class="no_margin">Long-chain fatty acids should avoided (see <a href="#ab-lipo-p.AgentsCircumstances_to_Avoid">Agents/Circumstances to Avoid</a>).</p></div></dd><dt>3. </dt><dd><div id="ab-lipo-p.TF.4.3"><p class="no_margin"><a class="bk_pop" href="#ab-lipo-p.REF.black.1991.520">Black et al [1991]</a></p></div></dd><dt>4. </dt><dd><div id="ab-lipo-p.TF.4.4"><p class="no_margin">Vitamin A dosing should be titrated to serum beta-carotene concentrations (see <a href="#ab-lipo-p.Surveillance">Surveillance</a>).</p></div></dd><dt>5. </dt><dd><div id="ab-lipo-p.TF.4.5"><p class="no_margin">While vitamin A toxicity is unlikely, it has been reported in one <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual with a normal serum vitamin A level who initiated vitamin A supplementation [<a class="bk_pop" href="#ab-lipo-p.REF.bishara.1982.767">Bishara et al 1982</a>].</p></div></dd><dt>6. </dt><dd><div id="ab-lipo-p.TF.4.6"><p class="no_margin">The target goal for vitamin A levels should be low normal to avoid hepatotoxicity.</p></div></dd><dt>7. </dt><dd><div id="ab-lipo-p.TF.4.7"><p class="no_margin">Despite supplementation, an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual will always have low vitamin E levels.</p></div></dd></dl></div></div></div></div><div id="ab-lipo-p.Prevention_of_Primary_Manifest"><h3>Prevention of Primary Manifestations</h3><p>Early treatment with vitamin E (100-300 IU/kg/day) may delay or prevent the development of neurologic dysfunction [<a class="bk_pop" href="#ab-lipo-p.REF.zamel.2008.19">Zamel et al 2008</a>].</p><p>Vitamin E supplementation may also delay or prevent the development of ophthalmoplegia and/or ptosis.</p><p>Vitamin A supplementation (100-400 IU/kg/day) may help to prevent corneal ulcers from developing.</p><p>See <a href="#ab-lipo-p.Treatment_of_Manifestations">Treatment of Manifestations</a>.</p></div><div id="ab-lipo-p.Prevention_of_Secondary_Compli"><h3>Prevention of Secondary Complications</h3><p>See <a href="#ab-lipo-p.Treatment_of_Manifestations">Treatment of Manifestations</a>.</p></div><div id="ab-lipo-p.Surveillance"><h3>Surveillance</h3><p>Clinical evaluation every six to 12 months, including assessment of diet and any gastrointestinal or neurologic symptoms, is recommended. The following evaluations are also recommended for abetalipoproteinemia [<a class="bk_pop" href="#ab-lipo-p.REF.lee.2014.333">Lee &#x00026; Hegele 2014</a>] (see <a class="figpopup" href="/books/NBK532447/table/ab-lipo-p.T.recommended_surveillance_for/?report=objectonly" target="object" rid-figpopup="figablipopTrecommendedsurveillancefor" rid-ob="figobablipopTrecommendedsurveillancefor">Table 5</a>).</p><div id="ab-lipo-p.T.recommended_surveillance_for" class="table"><h3><span class="label">Table 5. </span></h3><div class="caption"><p>Recommended Surveillance for Individuals with Abetalipoproteinemia</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK532447/table/ab-lipo-p.T.recommended_surveillance_for/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__ab-lipo-p.T.recommended_surveillance_for_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_ab-lipo-p.T.recommended_surveillance_for_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Organ System</th><th id="hd_h_ab-lipo-p.T.recommended_surveillance_for_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Evaluation</th><th id="hd_h_ab-lipo-p.T.recommended_surveillance_for_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Frequency</th></tr></thead><tbody><tr><td headers="hd_h_ab-lipo-p.T.recommended_surveillance_for_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>General</b></td><td headers="hd_h_ab-lipo-p.T.recommended_surveillance_for_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Assessment of growth parameters</td><td headers="hd_h_ab-lipo-p.T.recommended_surveillance_for_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">At every visit</td></tr><tr><td headers="hd_h_ab-lipo-p.T.recommended_surveillance_for_1_1_1_1" rowspan="4" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><b>Gastrointestinal</b></td><td headers="hd_h_ab-lipo-p.T.recommended_surveillance_for_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Lipid profile&#x000a0;<sup>1</sup></td><td headers="hd_h_ab-lipo-p.T.recommended_surveillance_for_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Every several years&#x000a0;<sup>2</sup></td></tr><tr><td headers="hd_h_ab-lipo-p.T.recommended_surveillance_for_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Liver function tests&#x000a0;<sup>3</sup></td><td headers="hd_h_ab-lipo-p.T.recommended_surveillance_for_1_1_1_3" rowspan="2" colspan="1" style="text-align:left;vertical-align:middle;">Annually</td></tr><tr><td headers="hd_h_ab-lipo-p.T.recommended_surveillance_for_1_1_1_2" colspan="1" scope="col" rowspan="1" style="text-align:left;vertical-align:middle;">Fat-soluble vitamin levels&#x000a0;<sup>4,&#x000a0;5</sup></td></tr><tr><td headers="hd_h_ab-lipo-p.T.recommended_surveillance_for_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Liver ultrasound</td><td headers="hd_h_ab-lipo-p.T.recommended_surveillance_for_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Every 3 years&#x000a0;<sup>6</sup></td></tr><tr><td headers="hd_h_ab-lipo-p.T.recommended_surveillance_for_1_1_1_1" rowspan="3" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><b>Hematologic</b></td><td headers="hd_h_ab-lipo-p.T.recommended_surveillance_for_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Complete blood count</td><td headers="hd_h_ab-lipo-p.T.recommended_surveillance_for_1_1_1_3" rowspan="5" colspan="1" style="text-align:left;vertical-align:middle;">Annually</td></tr><tr><td headers="hd_h_ab-lipo-p.T.recommended_surveillance_for_1_1_1_2" colspan="1" scope="col" rowspan="1" style="text-align:left;vertical-align:middle;">INR</td></tr><tr><td headers="hd_h_ab-lipo-p.T.recommended_surveillance_for_1_1_1_2" colspan="1" scope="col" rowspan="1" style="text-align:left;vertical-align:middle;">Reticulocyte count</td></tr><tr><td headers="hd_h_ab-lipo-p.T.recommended_surveillance_for_1_1_1_1" rowspan="2" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><b>Endocrinologic</b></td><td headers="hd_h_ab-lipo-p.T.recommended_surveillance_for_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Serum calcium, phosphate, &#x00026; uric acid</td></tr><tr><td headers="hd_h_ab-lipo-p.T.recommended_surveillance_for_1_1_1_2" colspan="1" scope="col" rowspan="1" style="text-align:left;vertical-align:middle;">Serum TSH</td></tr><tr><td headers="hd_h_ab-lipo-p.T.recommended_surveillance_for_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Eyes</b></td><td headers="hd_h_ab-lipo-p.T.recommended_surveillance_for_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Ophthalmologic evaluation</td><td headers="hd_h_ab-lipo-p.T.recommended_surveillance_for_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Every 6-12 months&#x000a0;<sup>6</sup></td></tr><tr><td headers="hd_h_ab-lipo-p.T.recommended_surveillance_for_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Neurologic</b></td><td headers="hd_h_ab-lipo-p.T.recommended_surveillance_for_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Neurologic examination</td><td headers="hd_h_ab-lipo-p.T.recommended_surveillance_for_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Every 6-12 months&#x000a0;<sup>6</sup></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">INR = international normalized ratio; TSH = thyroid stimulating hormone</p></div></dd><dt>1. </dt><dd><div id="ab-lipo-p.TF.5.1"><p class="no_margin">Lipid profile typically includes total cholesterol, triglyceride concentration, LDL-cholesterol, HDL-cholesterol, apo B, and apo A-I.</p></div></dd><dt>2. </dt><dd><div id="ab-lipo-p.TF.5.2"><p class="no_margin">Annual lipid profile evaluation is not absolutely necessary, as lipid levels often remain stable over long periods of time.</p></div></dd><dt>3. </dt><dd><div id="ab-lipo-p.TF.5.3"><p class="no_margin">AST, ALT, GGT, total and direct bilirubin, alkaline phosphatase, and albumin</p></div></dd><dt>4. </dt><dd><div id="ab-lipo-p.TF.5.4"><p class="no_margin">Vitamin A (retinol), 25-OH vitamin D, and plasma or red blood cell (RBC) vitamin E</p></div></dd><dt>5. </dt><dd><div id="ab-lipo-p.TF.5.5"><p class="no_margin">Vitamin A dosing should be titrated to serum beta-carotene concentrations.</p></div></dd><dt>6. </dt><dd><div id="ab-lipo-p.TF.5.6"><p class="no_margin">In <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals age &#x0003e;10 years</p></div></dd></dl></div></div></div></div><div id="ab-lipo-p.AgentsCircumstances_to_Avoid"><h3>Agents/Circumstances to Avoid</h3><p>Avoid fatty foods, particularly those rich in long-chain fatty acids.</p></div><div id="ab-lipo-p.Evaluation_of_Relatives_at_Ris"><h3>Evaluation of Relatives at Risk</h3><p>It is appropriate to evaluate apparently asymptomatic older and younger sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> in order to identify as early as possible those who would benefit from prompt initiation of treatment and preventive measures.</p><p>Evaluations can include:</p><ul><li class="half_rhythm"><div>A full lipid profile and apo B determination;</div></li><li class="half_rhythm"><div>Molecular genetic testing if the pathogenic variants in the family are known.</div></li></ul><p>Note: In classic abetalipoproteinemia, <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> sibs will present shortly after birth with failure to thrive, diarrhea, vomiting, and malabsorption of fat.</p><p>See <a href="#ab-lipo-p.Related_Genetic_Counseling_Iss">Genetic Counseling</a> for issues related to testing of at-risk relatives for <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> purposes.</p></div><div id="ab-lipo-p.Pregnancy_Management"><h3>Pregnancy Management</h3><p>Vitamin A excess can be harmful to the developing fetus. Therefore, women who are pregnant or who are planning to become pregnant should reduce their vitamin A supplement dose by 50%. Additionally, close monitoring of serum beta carotene levels throughout pregnancy is recommended [<a class="bk_pop" href="#ab-lipo-p.REF.lee.2014.333">Lee &#x00026; Hegele 2014</a>].</p><p>Because vitamin A is an essential vitamin, however, vitamin A supplementation for <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> women should not be discontinued during pregnancy. Vitamin A deficiency can lead to maternal morbidity.</p><p>See <a href="http://www.mothertobaby.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">MotherToBaby</a> for further information on medication use during pregnancy.</p></div><div id="ab-lipo-p.Therapies_Under_Investigation"><h3>Therapies Under Investigation</h3><p>Search <a href="http://clinicaltrials.gov/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ClinicalTrials.gov</a> in the US and <a href="http://www.ClinicalTrialsRegister.eu" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.ClinicalTrialsRegister.eu</a> in Europe for information on clinical studies for a wide range of diseases and conditions.</p></div></div><div id="ab-lipo-p.Genetic_Counseling"><h2 id="_ab-lipo-p_Genetic_Counseling_">Genetic Counseling</h2><p>
<i>Genetic counseling is the process of providing individuals and families with
information on the nature, inheritance, and implications of genetic disorders to help them
make informed medical and personal decisions. The following section deals with genetic
risk assessment and the use of family history and genetic testing to clarify genetic
status for family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with a genetics
professional</i>. &#x02014;ED.</p><div id="ab-lipo-p.Mode_of_Inheritance"><h3>Mode of Inheritance</h3><p>Abetalipoproteinemia is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> manner.</p></div><div id="ab-lipo-p.Risk_to_Family_Members"><h3>Risk to Family Members</h3><p><b>Parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>The parents of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> child are obligate heterozygotes (i.e., carriers of one <i>MTTP</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>).</div></li><li class="half_rhythm"><div>Heterozygotes (carriers) are asymptomatic, have normal lipid profiles, and are not at risk of developing the disorder.</div></li></ul><p><b>Sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>At conception, each sib of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual has a 25% chance of being affected, a 50% chance of being an asymptomatic <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a>, and a 25% chance of being unaffected and not a carrier.</div></li><li class="half_rhythm"><div>Heterozygotes (carriers) are asymptomatic and are not at risk of developing the disorder.</div></li></ul><p><b>Offspring of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> Unless an individual with abetalipoproteinemia has children with an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual or a <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a>, his/her offspring will be obligate heterozygotes (carriers) for a <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>MTTP</i>.</p><p><b>Other family members.</b> Each sib of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>'s parents is at a 50% risk of being a <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> of a <i>MTTP</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</p></div><div id="ab-lipo-p.Carrier_Heterozygote_Detection"><h3>Carrier (Heterozygote) Detection</h3><p>Carrier testing for at-risk relatives requires prior identification of the <i>MTTP</i> pathogenic variants in the family.</p></div><div id="ab-lipo-p.Related_Genetic_Counseling_Iss"><h3>Related Genetic Counseling Issues</h3><p>See Management, <a href="#ab-lipo-p.Evaluation_of_Relatives_at_Ris">Evaluation of Relatives at Risk</a> for information on evaluating at-risk relatives for the purpose of early diagnosis and treatment.</p><p><b>Family planning</b></p><ul><li class="half_rhythm"><div>The optimal time for determination of genetic risk, clarification of <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> status, and discussion of the availability of prenatal testing is before pregnancy.</div></li><li class="half_rhythm"><div>It is appropriate to offer <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> (including discussion of potential risks to offspring and reproductive options) to young adults who are <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>, are carriers, or are at risk of being carriers.</div></li></ul><p><b>DNA banking</b> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals.</p></div><div id="ab-lipo-p.Prenatal_Testing_and_Preimplan"><h3>Prenatal Testing and Preimplantation Genetic Diagnosis</h3><p>Once the <i>MTTP</i> pathogenic variants have been identified in an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member, prenatal testing for a pregnancy at increased risk and <a class="def" href="/books/n/gene/glossary/def-item/preimplantation-genetic-diagnosis/">preimplantation genetic diagnosis</a> are possible.</p><p>Differences in perspective may exist among medical professionals and within families regarding the use of prenatal testing, particularly if the testing is being considered for the purpose of pregnancy termination rather than early diagnosis. While most centers would consider decisions regarding prenatal testing to be the choice of the parents, discussion of these issues is appropriate.</p></div></div><div id="ab-lipo-p.Resources"><h2 id="_ab-lipo-p_Resources_">Resources</h2><p>
<i>GeneReviews staff has selected the following disease-specific and/or umbrella
support organizations and/or registries for the benefit of individuals with this disorder
and their families. GeneReviews is not responsible for the information provided by other
organizations. For information on selection criteria, click <a href="/books/n/gene/app4/">here</a>.</i></p><ul><li class="half_rhythm"><div><b>Genetic and Rare Diseases Information Center (GARD)</b></div><div><a href="https://rarediseases.info.nih.gov/diseases/5/abetalipoproteinemia" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Abetalipoproteinemia</a></div></li><li class="half_rhythm"><div><b>National Library of Medicine Genetics Home Reference</b></div><div><a href="https://ghr.nlm.nih.gov/condition/abetalipoproteinemia" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Abetalipoproteinemia</a></div></li><li class="half_rhythm"><div><b>National Organization for Rare Disorders (NORD)</b></div><div><a href="https://rarediseases.org/rare-diseases/abetalipoproteinemia/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Abetalipoproteinemia</a></div></li></ul></div><div id="ab-lipo-p.Molecular_Genetics"><h2 id="_ab-lipo-p_Molecular_Genetics_">Molecular Genetics</h2><p><i>Information in the Molecular Genetics and OMIM tables may differ from that elsewhere in the GeneReview: tables may contain more recent information. &#x02014;</i>ED.</p><div id="ab-lipo-p.molgen.TA" class="table"><h3><span class="label">Table A.</span></h3><div class="caption"><p>Abetalipoproteinemia: Genes and Databases</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK532447/table/ab-lipo-p.molgen.TA/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__ab-lipo-p.molgen.TA_lrgtbl__"><table class="no_bottom_margin"><tbody><tr><th id="hd_b_ab-lipo-p.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">Gene</th><th id="hd_b_ab-lipo-p.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">Chromosome Locus</th><th id="hd_b_ab-lipo-p.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">Protein</th><th id="hd_b_ab-lipo-p.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">Locus-Specific Databases</th><th id="hd_b_ab-lipo-p.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">HGMD</th><th id="hd_b_ab-lipo-p.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;">ClinVar</th></tr><tr><td headers="hd_b_ab-lipo-p.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/4547" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>MTTP</i></a></td><td headers="hd_b_ab-lipo-p.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=4547" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">4q23</a></td><td headers="hd_b_ab-lipo-p.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/P55157" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Microsomal triglyceride transfer protein large subunit</a></td><td headers="hd_b_ab-lipo-p.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://databases.lovd.nl/shared/genes/MTTP" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">MTTP database</a></td><td headers="hd_b_ab-lipo-p.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=MTTP" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">MTTP</a></td><td headers="hd_b_ab-lipo-p.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=MTTP[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">MTTP</a></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div id="ab-lipo-p.TFA.1"><p class="no_margin">Data are compiled from the following standard references: <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> from
<a href="http://www.genenames.org/index.html" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">HGNC</a>;
<a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> from
<a href="http://www.omim.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">OMIM</a>;
protein from <a href="http://www.uniprot.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">UniProt</a>.
For a description of databases (Locus Specific, HGMD, ClinVar) to which links are provided, click
<a href="/books/n/gene/app1/">here</a>.</p></div></dd></dl></div></div></div><div id="ab-lipo-p.molgen.TB" class="table"><h3><span class="label">Table B.</span></h3><div class="caption"><p>OMIM Entries for Abetalipoproteinemia (<a href="/omim/157147,200100" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">View All in OMIM</a>) </p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK532447/table/ab-lipo-p.molgen.TB/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__ab-lipo-p.molgen.TB_lrgtbl__"><table><tbody><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/157147" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">157147</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">MICROSOMAL TRIGLYCERIDE TRANSFER PROTEIN; MTTP</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/200100" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">200100</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">ABETALIPOPROTEINEMIA; ABL</td></tr></tbody></table></div></div><div id="ab-lipo-p.Molecular_Genetic_Pathogenesis"><h3>Molecular Genetic Pathogenesis</h3><p>The microsomal triglyceride transfer protein is an essential cofactor for the assembly and secretion of the apolipoprotein (apo) B-containing lipoproteins: chylomicrons from the intestine and very low-density lipoprotein from the liver. Active microsomal triglyceride transfer protein consists of two subunits, the unique MTTP subunit (encoded by <i>MTTP</i>) and a ubiquitously expressed protein disulfide isomerase (PDI) subunit (encoded by <i>P4HB</i>). PDI maintains the solubility of the heterodimeric complex. In individuals with abetalipoproteinemia, the <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> pathogenic variants in <i>MTTP</i> result in the inability of apoB-containing lipoprotein particles to be secreted. The absence of apoB-containing lipoproteins and deficiency of fat-soluble vitamins in the circulation lead to a variety of clinical manifestations.</p><p><b>Gene structure.</b> The longer transcript variant of <i>MTTP</i> (<a class="figpopup" href="/books/NBK532447/table/ab-lipo-p.T.mttp_variants_discussed_in_t/?report=objectonly" target="object" rid-figpopup="figablipopTmttpvariantsdiscussedint" rid-ob="figobablipopTmttpvariantsdiscussedint">NM_000253.3</a>) has 19 exons with the first being noncoding.</p><p><b>Pathogenic variants.</b> Approximately 60 <i>MTTP</i> pathogenic variants have been identified; they are interspersed throughout the <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> and are not found with increased prevalence in any specific ethnic group. The majority of these are <a class="def" href="/books/n/gene/glossary/def-item/inactivating/">inactivating</a> variants (<a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, <a class="def" href="/books/n/gene/glossary/def-item/splicing/">splicing</a>, and small indels). In vitro studies have shown that several pathogenic <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> variants affect MTTP function (see <b>Abnormal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a></b>).</p><div id="ab-lipo-p.T.mttp_variants_discussed_in_t" class="table"><h3><span class="label">Table 6. </span></h3><div class="caption"><p><i>MTTP</i> Variants Discussed in This <i>GeneReview</i></p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK532447/table/ab-lipo-p.T.mttp_variants_discussed_in_t/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__ab-lipo-p.T.mttp_variants_discussed_in_t_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_ab-lipo-p.T.mttp_variants_discussed_in_t_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">DNA Nucleotide Change</th><th id="hd_h_ab-lipo-p.T.mttp_variants_discussed_in_t_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Predicted Protein Change</th><th id="hd_h_ab-lipo-p.T.mttp_variants_discussed_in_t_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Reference<br />Sequences</th></tr></thead><tbody><tr><td headers="hd_h_ab-lipo-p.T.mttp_variants_discussed_in_t_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.1304T&#x0003e;A</td><td headers="hd_h_ab-lipo-p.T.mttp_variants_discussed_in_t_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Leu435His</td><td headers="hd_h_ab-lipo-p.T.mttp_variants_discussed_in_t_1_1_1_3" rowspan="5" colspan="1" style="text-align:left;vertical-align:middle;"><a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_000253.3" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_000253<wbr style="display:inline-block"></wbr>​.3</a><br /><a href="https://www.ncbi.nlm.nih.gov/protein/NP_000244.2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NP_000244<wbr style="display:inline-block"></wbr>​.2</a></td></tr><tr><td headers="hd_h_ab-lipo-p.T.mttp_variants_discussed_in_t_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.1619G&#x0003e;A</td><td headers="hd_h_ab-lipo-p.T.mttp_variants_discussed_in_t_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Arg540His</td></tr><tr><td headers="hd_h_ab-lipo-p.T.mttp_variants_discussed_in_t_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.1769G&#x0003e;T</td><td headers="hd_h_ab-lipo-p.T.mttp_variants_discussed_in_t_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Ser590Ile</td></tr><tr><td headers="hd_h_ab-lipo-p.T.mttp_variants_discussed_in_t_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.2237G&#x0003e;A</td><td headers="hd_h_ab-lipo-p.T.mttp_variants_discussed_in_t_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Gly746Glu</td></tr><tr><td headers="hd_h_ab-lipo-p.T.mttp_variants_discussed_in_t_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.2338A&#x0003e;T</td><td headers="hd_h_ab-lipo-p.T.mttp_variants_discussed_in_t_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Asn780Tyr</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">Note on variant classification: Variants listed in the table have been provided by the authors. <i>GeneReviews</i> staff have not independently verified the classification of variants.</p></div></dd><dt></dt><dd><div><p class="no_margin">Note on nomenclature: <i>GeneReviews</i> follows the standard naming conventions of the Human Genome Variation Society (<a href="http://varnomen.hgvs.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">varnomen<wbr style="display:inline-block"></wbr>​.hgvs.org</a>). See <a href="/books/n/gene/app3/">Quick Reference</a> for an explanation of nomenclature.</p></div></dd></dl></div></div></div><p><b>Normal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> MTTP consists of 894 amino acids with a signal peptide of 18 residues and three distinct structural regions: an amino-terminal &#x003b2;-barrel <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a> (amino acids 22-297), a central &#x003b1;-helical region (298-603), and a carboxyl-terminal domain (604-894).</p><p><b>Abnormal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> Null alleles and C-terminal truncations result in the inability to produce full-length functional MTTP. The functional consequences of several pathogenic <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> variants have been described; p.Arg540His results in defective interaction with PDI, with the mutated MTTP remaining as an insoluble aggregate [<a class="bk_pop" href="#ab-lipo-p.REF.rehberg.1996.29945">Rehberg et al 1996</a>], while p.Leu435His and p.Ser590Ile exhibit negligible lipid transfer activity [<a class="bk_pop" href="#ab-lipo-p.REF.di_filippo.2012.548">Di Filippo et al 2012</a>, <a class="bk_pop" href="#ab-lipo-p.REF.khatun.2013.1541">Khatun et al 2013</a>]. Pathogenic variants p.Gly746Glu and p.Asn780Tyr are able to interact with PDI, but cannot transfer lipids [<a class="bk_pop" href="#ab-lipo-p.REF.ohashi.2000.1199">Ohashi et al 2000</a>, <a class="bk_pop" href="#ab-lipo-p.REF.khatun.2013.1541">Khatun et al 2013</a>].</p></div></div><div id="ab-lipo-p.References"><h2 id="_ab-lipo-p_References_">References</h2><div id="ab-lipo-p.Literature_Cited"><h3>Literature Cited</h3><ul class="simple-list"><li class="half_rhythm"><div class="bk_ref" id="ab-lipo-p.REF.bishara.1982.767">Bishara S, Merin S, Cooper M, Azizi E, Delpre G, Deckelbaum RJ. Combined vitamin A and E therapy prevents retinal electrophysiological deterioration in abetalipoproteinemia. <span><span class="ref-journal">Br J Ophthalmol. </span>1982;<span class="ref-vol">66</span>:767–70.</span> [<a href="/pmc/articles/PMC1039925/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1039925</span></a>] [<a href="/pubmed/7171526" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 7171526</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ab-lipo-p.REF.black.1991.520">Black DD, Hay RV, Rohwer-Nutter PL, Ellinas H, Stephens JK, Sherman H, Teng BB, Whitington PF, Davidson NO. Intestinal and hepatic apolipoprotein B gene expression in abetalipoproteinemia. <span><span class="ref-journal">Gastroenterology. </span>1991;<span class="ref-vol">101</span>:520–8.</span> [<a href="/pubmed/2065927" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 2065927</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ab-lipo-p.REF.cogan.1984.991">Cogan DG, Rodrigues M, Chu FC, Schaefer EJ. Ocular abnormalities in abetalipoproteinemia. A clinicopathologic correlation. <span><span class="ref-journal">Ophthalmology. </span>1984;<span class="ref-vol">91</span>:991–8.</span> [<a href="/pubmed/6493710" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 6493710</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ab-lipo-p.REF.di_filippo.2012.548">Di Filippo M, Cr&#x000e9;halet H, Samson-Bouma ME, Bonnet V, Aggerbeck LP, Rab&#x000e8;s JP, Gottrand F, Luc G, Bozon D, Sassolas A. Molecular and functional analysis of two new MTTP gene mutations in an atypical case of abetalipoproteinemia. <span><span class="ref-journal">J Lipid Res. </span>2012;<span class="ref-vol">53</span>:548–55.</span> [<a href="/pmc/articles/PMC3276478/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3276478</span></a>] [<a href="/pubmed/22236406" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22236406</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ab-lipo-p.REF.di_filippo.2014.891">Di Filippo M, Moulin P, Roy P, Samson-Bouma ME, Collardeau-Frachon S, Chebel-Dumont S, Peretti N, Dumortier J, Zoulim F, Fontanges T, Parini R, Rigoldi M, Furlan F, Mancini G, Bonnefont-Rousselot D, Bruckert E, Schmitz J, Scoazec JY, Charri&#x000e8;re S, Villar-Fimbel S, Gottrand F, Dubern B, Doummar D, Joly F, Liard-Meillon ME, Lachaux A, Sassolas A. Homozygous MTTP and APOB mutations may lead to hepatic steatosis and fibrosis despite metabolic differences in congenital hypocholesterolemia. <span><span class="ref-journal">J Hepatol. </span>2014;<span class="ref-vol">61</span>:891–902.</span> [<a href="/pubmed/24842304" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24842304</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ab-lipo-p.REF.kane.2001">Kane JP, Havel R. Disorders of the biogenesis and secretion of lipoproteins containing the B apolipoproteins. In: Scriver CR, Beaudet AL, Sly WS, Valle D, Vogelstein B, eds. <em>The Metabolic and Molecular Bases of Inherited Disease</em>. 8 ed. Vol 2. New York, NY: McGraw-Hill; 2001:2717-52.</div></li><li class="half_rhythm"><div class="bk_ref" id="ab-lipo-p.REF.khatun.2013.1541">Khatun I, Walsh MT, Hussain MM. Loss of both phospholipid and triglyceride transfer activities of microsomal triglyceride transfer protein in abetalipoproteinemia. <span><span class="ref-journal">J Lipid Res. </span>2013;<span class="ref-vol">54</span>:1541–9.</span> [<a href="/pmc/articles/PMC3646455/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3646455</span></a>] [<a href="/pubmed/23475612" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23475612</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ab-lipo-p.REF.lee.2014.333">Lee J, Hegele RA. Abetalipoproteinemia and homozygous hypobetalipoproteinemia: a framework for diagnosis and management. <span><span class="ref-journal">J Inherit Metab Dis. </span>2014;<span class="ref-vol">37</span>:333–9.</span> [<a href="/pubmed/24288038" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24288038</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ab-lipo-p.REF.ohashi.2000.1199">Ohashi K, Ishibashi S, Osuga J, Tozawa R, Harada K, Yahagi N, Shionoiri F, Iizuka Y, Tamura Y, Nagai R, Illingworth DR, Gotoda T, Yamada N. Novel mutations in the microsomal triglyceride transfer protein gene causing abetalipoproteinemia. <span><span class="ref-journal">J Lipid Res. </span>2000;<span class="ref-vol">41</span>:1199–204.</span> [<a href="/pubmed/10946006" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10946006</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ab-lipo-p.REF.paquette.2016.1030">Paquette M, Dufour R, Hegele RA, Baass A. A tale of 2 cousins: an atypical and a typical case of abetalipoproteinemia. <span><span class="ref-journal">J Clin Lipidol. </span>2016;<span class="ref-vol">10</span>:1030–4.</span> [<a href="/pubmed/27578136" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 27578136</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ab-lipo-p.REF.rehberg.1996.29945">Rehberg EF, Samson-Bouma ME, Kienzle B, Blinderman L, Jamil H, Wetterau JR, Aggerbeck LP, Gordon DA. A novel abetalipoproteinemia genotype. Identification of a missense mutation in the 97-kDa subunit of the microsomal triglyceride transfer protein that prevents complex formation with protein disulfide isomerase. <span><span class="ref-journal">J Biol Chem. </span>1996;<span class="ref-vol">271</span>:29945–52.</span> [<a href="/pubmed/8939939" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 8939939</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ab-lipo-p.REF.tanyel.1997.197">Tanyel MC, Mancano LD. Neurologic findings in vitamin E deficiency. <span><span class="ref-journal">Am Fam Physician. </span>1997;<span class="ref-vol">55</span>:197–201.</span> [<a href="/pubmed/9012278" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9012278</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ab-lipo-p.REF.zamel.2008.19">Zamel R, Kand R, Pollex RL, Hegele RA. Abetalipoproteinemia: two cases and literature review. <span><span class="ref-journal">Orphanet J Rare Dis. </span>2008;<span class="ref-vol">3</span>:19.</span> [<a href="/pmc/articles/PMC2467409/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2467409</span></a>] [<a href="/pubmed/18611256" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18611256</span></a>]</div></li></ul></div></div><div id="ab-lipo-p.Chapter_Notes"><h2 id="_ab-lipo-p_Chapter_Notes_">Chapter Notes</h2><div id="ab-lipo-p.Acknowledgments"><h3>Acknowledgments</h3><p>RAH has received operating grants from the Canadian Institutes of Health Research (Foundation Grant), the Heart and Stroke Foundation of Ontario (G-15-0009214), and Genome Canada through Genome Quebec (award 4530).</p></div><div id="ab-lipo-p.Revision_History"><h3>Revision History</h3><ul><li class="half_rhythm"><div>25 October 2018 (ma) Review posted live</div></li><li class="half_rhythm"><div>23 January 2018 (jb) Original submission</div></li></ul></div></div><div id="bk_toc_contnr"></div></div></div>
            <div class="post-content"><div><div class="half_rhythm"><a href="/books/about/copyright/">Copyright</a> © 1993-2019, University of Washington, Seattle. GeneReviews is
a registered trademark of the University of Washington, Seattle. All rights
reserved.<p class="small">GeneReviews® chapters are owned by the University of Washington. Permission is
hereby granted to reproduce, distribute, and translate copies of content materials for
noncommercial research purposes only, provided that (i) credit for source (<a href="http://www.genereviews.org/" ref="pagearea=meta&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">http://www.genereviews.org/</a>) and copyright (© 1993-2019 University of
Washington) are included with each copy; (ii) a link to the original material is provided
whenever the material is published elsewhere on the Web; and (iii) reproducers,
distributors, and/or translators comply with the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>. No further modifications are allowed. For clarity, excerpts
of GeneReviews chapters for use in lab reports and clinic notes are a permitted
use.</p><p class="small">For more information, see the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>.</p><p class="small">For questions regarding permissions or whether a specified use is allowed,
contact: <a href="mailto:dev@null" data-email="ude.wu@tssamda" class="oemail">ude.wu@tssamda</a>.</p></div><div class="small"><span class="label">Bookshelf ID: NBK532447</span><span class="label">PMID: <a href="/pubmed/30358967" title="PubMed record of this page" ref="pagearea=meta&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">30358967</a></span></div><div style="margin-top:2em" class="bk_noprnt"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/pfic/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/acp/" title="Next page in this title">Next &gt;</a></div></div></div></div>
            
        </div>

        <!-- Custom content below content -->
        <div class="col4">
            
        </div>
        
        
        <!-- Book content -->
        
        <!-- Custom contetnt below bottom nav -->
        <div class="col5">
            
        </div>
    </div>

    <div id="rightcolumn" class="four_col col last">
        <!-- Custom content above discovery portlets -->
        <div class="col6">
            <div id="ncbi_share_book"><a href="#" class="ncbi_share" data-ncbi_share_config="popup:false,shorten:true" ref="id=NBK532447&amp;db=books">Share</a></div>

        </div>
        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Views</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PDF_download" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/NBK532447/?report=reader">PubReader</a></li><li><a href="/books/NBK532447/?report=printable">Print View</a></li><li><a data-jig="ncbidialog" href="#_ncbi_dlg_citbx_NBK532447" data-jigconfig="width:400,modal:true">Cite this Page</a><div id="_ncbi_dlg_citbx_NBK532447" style="display:none" title="Cite this Page"><div class="bk_tt">Burnett JR, Hooper AJ, Hegele RA. Abetalipoproteinemia. 2018 Oct 25. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. <span class="bk_cite_avail"></span></div></div></li><li><a href="/books/NBK532447/pdf/Bookshelf_NBK532447.pdf">PDF version of this page</a> (438K)</li><li><a href="#" class="toggle-glossary-link" title="Enable/disable links to the glossary">Disable Glossary Links</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>In this GeneReview</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="page-toc" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="#ab-lipo-p.Summary" ref="log$=inpage&amp;link_id=inpage">Summary</a></li><li><a href="#ab-lipo-p.Diagnosis" ref="log$=inpage&amp;link_id=inpage">Diagnosis</a></li><li><a href="#ab-lipo-p.Clinical_Characteristics" ref="log$=inpage&amp;link_id=inpage">Clinical Characteristics</a></li><li><a href="#ab-lipo-p.Genetically_Related_Allelic_Di" ref="log$=inpage&amp;link_id=inpage">Genetically Related (Allelic) Disorders</a></li><li><a href="#ab-lipo-p.Differential_Diagnosis" ref="log$=inpage&amp;link_id=inpage">Differential Diagnosis</a></li><li><a href="#ab-lipo-p.Management" ref="log$=inpage&amp;link_id=inpage">Management</a></li><li><a href="#ab-lipo-p.Genetic_Counseling" ref="log$=inpage&amp;link_id=inpage">Genetic Counseling</a></li><li><a href="#ab-lipo-p.Resources" ref="log$=inpage&amp;link_id=inpage">Resources</a></li><li><a href="#ab-lipo-p.Molecular_Genetics" ref="log$=inpage&amp;link_id=inpage">Molecular Genetics</a></li><li><a href="#ab-lipo-p.References" ref="log$=inpage&amp;link_id=inpage">References</a></li><li><a href="#ab-lipo-p.Chapter_Notes" ref="log$=inpage&amp;link_id=inpage">Chapter Notes</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>GeneReviews Links</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="source-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/n/gene/advanced/"><i>GeneReviews</i> Advanced Search</a></li><li><a href="/books/n/gene/glossary/"><i>GeneReviews</i> Glossary</a></li><li><a href="/books/n/gene/resource_mats/">Resource Materials</a> <span class="bk_hlight1">NEW FEATURE</span></li><li><a href="/books/n/gene/updates/">New in <i>GeneReviews</i></a></li><li><a href="/books/n/gene/authors/">Author List</a></li><li><a href="/books/n/gene/prospective_authors/">For Current/Prospective Authors</a></li><li><a href="/books/n/gene/GRpersonnel/"><i>GeneReviews</i> Personnel</a></li><li><a href="/books/n/gene/howto_linkin/">Download/Link to <i>GeneReviews</i></a></li><li><a href="/books/n/gene/contact_us/">Contact Us</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Tests in GTR by Gene</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=4547[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">MTTP</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Related information</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="discovery_db_links" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=omim&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_omim&amp;IdsFromResult=4637622" ref="log$=recordlinks">OMIM</a><div class="brieflinkpop offscreen_noflow">Related OMIM records</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pmc&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pmc_refs&amp;IdsFromResult=4637622" ref="log$=recordlinks">PMC</a><div class="brieflinkpop offscreen_noflow">PubMed Central citations</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pubmed&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pubmed_refs&amp;IdsFromResult=4637622" ref="log$=recordlinks">PubMed</a><div class="brieflinkpop offscreen_noflow">Links to PubMed</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=gene&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_gene&amp;IdsFromResult=4637622" ref="log$=recordlinks">Gene</a><div class="brieflinkpop offscreen_noflow">Locus Links</div></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Similar articles in PubMed</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PBooksDiscovery_RA" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301489" ref="ordinalpos=1&amp;linkpos=1&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Glycogen Storage Disease Type I</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Glycogen Storage Disease Type I<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Bali DS, Chen YT, Austin S, Goldstein JL. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/24624460" ref="ordinalpos=1&amp;linkpos=2&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">EPB42</i>-Related Hereditary Spherocytosis</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">EPB42</i>-Related Hereditary Spherocytosis<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Kalfa TA, Connor JA, Begtrup AH. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/31751110" ref="ordinalpos=1&amp;linkpos=3&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Tangier Disease</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Tangier Disease<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Burnett JR, Hooper AJ, McCormick SPA, Hegele RA. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301501" ref="ordinalpos=1&amp;linkpos=4&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Polycystic Kidney Disease, Autosomal Recessive</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Polycystic Kidney Disease, Autosomal Recessive<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Sweeney WE, Avner ED. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301691" ref="ordinalpos=1&amp;linkpos=5&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Classic Galactosemia and Clinical Variant Galactosemia</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Classic Galactosemia and Clinical Variant Galactosemia<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Berry GT. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li></ul><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed_reviews&amp;uid=30358967" ref="ordinalpos=1&amp;log$=relatedreviews_seeall&amp;logdbfrom=pubmed">See reviews...</a><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed&amp;uid=30358967" ref="ordinalpos=1&amp;log$=relatedarticles_seeall&amp;logdbfrom=pubmed">See all...</a></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Recent Activity</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="recent_activity" id="Shutter"></a></div><div class="portlet_content"><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" id="HTDisplay" class=""><div class="action"><a href="javascript:historyDisplayState('ClearHT')">Clear</a><a href="javascript:historyDisplayState('HTOff')" class="HTOn">Turn Off</a><a href="javascript:historyDisplayState('HTOn')" class="HTOff">Turn On</a></div><ul id="activity"><li class="ra_rcd ralinkpopper two_line"><a class="htb ralinkpopperctrl" ref="log$=activity&amp;linkpos=1" href="/portal/utils/pageresolver.fcgi?recordid=5dfc904e39a66ee2bab0e715">Abetalipoproteinemia - GeneReviews®</a><div class="ralinkpop offscreen_noflow">Abetalipoproteinemia - GeneReviews®<div class="brieflinkpopdesc"></div></div><div class="tertiary"></div></li></ul><p class="HTOn">Your browsing activity is empty.</p><p class="HTOff">Activity recording is turned off.</p><p id="turnOn" class="HTOff"><a href="javascript:historyDisplayState('HTOn')">Turn recording back on</a></p><a class="seemore" href="/sites/myncbi/recentactivity">See more...</a></div></div></div>
        
        <!-- Custom content below discovery portlets -->
        <div class="col7">
            
        </div>
    </div>
</div>

<!-- Custom content after all -->
<div class="col8">
    
</div>
<div class="col9">
    
</div>

<script type="text/javascript" src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>
<script type="text/javascript">
    (function($){
        $('.skiplink').each(function(i, item){
            var href = $($(item).attr('href'));
            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
            $(item).on('click', function(event){
                event.preventDefault();
                $.scrollTo(href, 0, {
                    onAfter: function(){
                        href.focus();
                    }
                });
            });
        });
    })(jQuery);
</script>
                        </div>
                        <div class="bottom">
                            
                            <div id="NCBIFooter_dynamic">
    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>
    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2019-12-20T04:11:43-05:00&amp;Snapshot=%2Fprojects%2Fbooks%2FPBooks@5.22&amp;Host=portal104&amp;ncbi_phid=CE8B7C18DFC854010000000005510277&amp;ncbi_session=CE8B7C18DFC904E1_1361SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fbooks%2FNBK532447%2F&amp;Db=pmc&amp;folderID=134&amp;Ncbi_App=bookshelf&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>
    
</div>

                            <div class="footer" id="footer">
    
    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>
    <div id="external-disclaimer" class="offscreen_noflow">
        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.
    </div>    
    <div id="ncbifooter" class="contact_info">      
        <div id="footer-contents-right">
            <div id="nlm_thumb_logo">
                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>
            </div>
            <div id="nih_thumb_logo">
                <a href="https://www.nih.gov" title="NIH">NIH</a>
            </div>
            <div id="hhs_thumb_logo">
                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>
            </div>
            <div id="usagov_thumb_logo">
                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>
            </div>         
        </div>
        
        <div id="footer-contents-left">
            <p class="address vcard">
                <span class="url">
                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for
                        Biotechnology Information</a>,
                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>
                <span class="adr">
                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>
                    <span class="region">MD</span>, <span class="postal-code">20894</span>
                    <span class="country-name">USA</span>
                </span>
            </p>
            
            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>
        </div>
    </div>
    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    
    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>
</div>
                        </div>
                    </div>
                    <!--/.page-->
                </div>
                <!--/.wrap-->
            </div><!-- /.twelve_col -->
        </div>
        <!-- /.grid -->

        <span class="PAFAppResources"></span>
        
        <!-- BESelector tab -->
        
        
        
        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=books&amp;ncbi_pdid=book-part&amp;ncbi_acc=NBK532447&amp;ncbi_domain=gene&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/NBK532447/&amp;ncbi_pagename=Abetalipoproteinemia - GeneReviews® - NCBI Bookshelf&amp;ncbi_bookparttype=chapter&amp;ncbi_app=bookshelf" /></noscript>
        
        
        <!-- usually for JS scripts at page bottom -->
        <!--<component id="PageFixtures" label="styles"></component>-->
    

<!-- CE8B7C18DFC904E1_1361SID /projects/books/PBooks@5.22 portal104 v4.1.r585844 Mon, May 06 2019 02:53:16 -->

<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/js/3879255/4121861/3501987/4008961/3893018/3821238/4062932/4123007/4087685/4076480/3921943/3400083/3426610.js" snapshot="books"></script></body>
</html>